de Goede-Bolder A - Search Results

1

Endocrinologic disorders and optic pathway gliomas in children with neurofibromatosis type 1.

Cnossen MH, Stam EN, Cooiman LC, Simonsz HJ, Stroink H, Oranje AP, Halley DJ, de Goede-Bolder A, Niermeijer MF, de Muinck Keizer-Schrama SM. Cnossen MH, et al. Pediatrics. 1997 Oct;100(4):667-70. doi: 10.1542/peds.100.4.667. Pediatrics. 1997. PMID: 9310522 Free article. Review.

2

Diagnostic delay in neurofibromatosis type 1.

Cnossen MH, Smit FJ, de Goede-Bolder A, Frets PG, Duivenvoorden HJ, Niermeijer MF. Cnossen MH, et al. Eur J Pediatr. 1997 Jun;156(6):482-7. doi: 10.1007/s004310050644. Eur J Pediatr. 1997. PMID: 9208248

3

A prospective 10 year follow up study of patients with neurofibromatosis type 1.

Cnossen MH, de Goede-Bolder A, van den Broek KM, Waasdorp CM, Oranje AP, Stroink H, Simonsz HJ, van den Ouweland AM, Halley DJ, Niermeijer MF. Cnossen MH, et al. Arch Dis Child. 1998 May;78(5):408-12. doi: 10.1136/adc.78.5.408. Arch Dis Child. 1998. PMID: 9659085 Free PMC article.

4

Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia Children's Hospital.

Cnossen MH, Moons KG, Garssen MP, Pasmans NM, de Goede-Bolder A, Niermeijer MF, Grobbee DE. Cnossen MH, et al. J Med Genet. 1998 Aug;35(8):624-7. doi: 10.1136/jmg.35.8.624. J Med Genet. 1998. PMID: 9719365 Free PMC article.

5

[From gene to disease; neurofibromatosis type 1].

de Goede-Bolder A, Cnossen MH, Dooijes D, van den Ouweland AM, Niermeijer MF. de Goede-Bolder A, et al. Ned Tijdschr Geneeskd. 2001 Sep 8;145(36):1736-8. Ned Tijdschr Geneeskd. 2001. PMID: 11572174 Review. Dutch.

6

Deletions spanning the neurofibromatosis type 1 gene: implications for genotype-phenotype correlations in neurofibromatosis type 1?

Cnossen MH, van der Est MN, Breuning MH, van Asperen CJ, Breslau-Siderius EJ, van der Ploeg AT, de Goede-Bolder A, van den Ouweland AM, Halley DJ, Niermeijer MF. Cnossen MH, et al. Hum Mutat. 1997;9(5):458-64. doi: 10.1002/(SICI)1098-1004(1997)9:5<458::AID-HUMU13>3.0.CO;2-1. Hum Mutat. 1997. PMID: 9143927

7

Krab LC, Oostenbrink R, de Goede-Bolder A, Aarsen FK, Elgersma Y, Moll HA. Krab LC, et al. J Pediatr. 2009 Mar;154(3):420-5, 425.e1. doi: 10.1016/j.jpeds.2008.08.045. Epub 2008 Oct 31. J Pediatr. 2009. PMID: 18950800

8

The group medical appointment (GMA) in haemophilia and von Willebrand's disease: a new development in outpatient paediatric care.

Lock J, De Bruin A, Scholten M, Joosten M, Seesing FM, Beishuizen A, De Goede-Bolder A, Cnossen MH. Lock J, et al. Among authors: de goede bolder a. Haemophilia. 2012 Sep;18(5):766-72. doi: 10.1111/j.1365-2516.2012.02783.x. Epub 2012 Mar 28. Haemophilia. 2012. PMID: 22458923

9

Parental reports of health-related quality of life in young children with neurofibromatosis type 1: influence of condition specific determinants.

Oostenbrink R, Spong K, de Goede-Bolder A, Landgraf JM, Raat H, Moll HA. Oostenbrink R, et al. J Pediatr. 2007 Aug;151(2):182-6, 186.e1-2. doi: 10.1016/j.jpeds.2007.03.005. J Pediatr. 2007. PMID: 17643775

10

Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.

Krab LC, de Goede-Bolder A, Aarsen FK, Pluijm SM, Bouman MJ, van der Geest JN, Lequin M, Catsman CE, Arts WF, Kushner SA, Silva AJ, de Zeeuw CI, Moll HA, Elgersma Y. Krab LC, et al. JAMA. 2008 Jul 16;300(3):287-94. doi: 10.1001/jama.300.3.287. JAMA. 2008. PMID: 18632543 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page